TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma

Novel individual biomarkers are needed to guide therapeutic decisions for patients with head and neck cancer. We report for the first time, granulomas of TREM2-expressing multinucleated giant macrophages in keratin-rich tumor niches, as a biomarker of favorable prognosis and developed a deep-learning model to automate its quantification on routinely stained pathological slides.

Authors

Institutions

Publication Details

Journal
Cancer Discovery
Published
2024-09-13
DOI
https://doi.org/10.1158/2159-8290.cd-24-0018
Citations
15
Primary Topic
Immune cells in cancer
Type
article
Field-Weighted Citation Impact
3.61

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma

Alexandre Sayadi, Pierre Busson, Thomas Walter, Antoine Moya‐Plana et al.
15 citations
Cancer Discovery
Immune cells in cancer
3.61
article

TREM2-Expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma

Alexandre Sayadi, Pierre Busson, Thomas Walter, Antoine Moya‐Plana, Grégoire Gessain, Charles‐Antoine Dutertre, Nicolas Signolle, Anne Aupérin, Camille Blériot, Daniela Weidner, Philippe Gorphe, Stefan Uderhardt, Antonin Marchais, Jean‐Yves Scoazec, Sumanth Reddy Nakkireddy, Mathilde Bied, Florent Ginhoux, Kevin Mulder, Daniel Stockholm, Alix Marhic, Quentin Blampey, Joanne Guerlain, Marvin Lerousseau, Odile Casiraghi, Sophie Broutin, Ingrid Breuskin, Marion Classe, Maria Eugénia Marques Da Costa, Farah Sassi, Ahmed-Amine Anzali
article en
15 citations

Abstract

Novel individual biomarkers are needed to guide therapeutic decisions for patients with head and neck cancer. We report for the first time, granulomas of TREM2-expressing multinucleated giant macrophages in keratin-rich tumor niches, as a biomarker of favorable prognosis and developed a deep-learning model to automate its quantification on routinely stained pathological slides.

Cancer DiscoveryVol. 14(12)
Centre National de la Recherche Scientifique (FR), Inserm (FR), École Pratique des Hautes Études (FR), Friedrich-Alexander-Universität Erlangen-Nürnberg (DE), Shanghai Jiao Tong University (CN), Université Paris Cité (FR), Université Paris Sciences et Lettres (FR), Université Paris-Saclay (FR), Singapore Immunology Network (SG), Jacksonville College (US), Institut Gustave Roussy (FR), Sanofi (France) (FR), Sorbonne Université (FR), Institut Necker Enfants Malades (FR), Universitätsklinikum Erlangen (DE), Sorbonne Paris Cité (FR), La Ligue Contre le Cancer (FR), SingHealth Duke-NUS Academic Medical Centre (SG), CentraleSupélec (FR), Centre de Recherche Saint-Antoine (FR), Mayo Clinic in Florida (US), Médecins Sans Frontières (FR)
Fondation ARC pour la Recherche sur le Cancer, Institut National Du Cancer
Good health and well-being
Openalex Percentile: Top 6%
Immune cells in cancer
3.61
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.